Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis.
about
Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia.Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.Long non-coding RNA phosphatase and tensin homolog pseudogene 1 suppresses osteosarcoma cell growth via the phosphoinositide 3-kinase/protein kinase B signaling pathway.
P2860
Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Immunohistochemistry for p53 i ...... type, and have poor prognosis.
@en
Immunohistochemistry for p53 i ...... type, and have poor prognosis.
@nl
type
label
Immunohistochemistry for p53 i ...... type, and have poor prognosis.
@en
Immunohistochemistry for p53 i ...... type, and have poor prognosis.
@nl
prefLabel
Immunohistochemistry for p53 i ...... type, and have poor prognosis.
@en
Immunohistochemistry for p53 i ...... type, and have poor prognosis.
@nl
P2093
P2860
P921
P1433
P1476
Immunohistochemistry for p53 i ...... type, and have poor prognosis.
@en
P2093
Daniel A Arber
Robert S Ohgami
Sebastian Fernandez-Pol
P2860
P2888
P304
P356
10.1038/MODPATHOL.2016.206
P577
2016-12-09T00:00:00Z